EU To Fund Vaccine Research In Nigeria With €18 Million

At the meeting, Isopi, who was represented by Prof. Leila Mathieu, said that the EU was aligned with the nation’s priorities.

She added that the development of the plan was timely and could not come at a better moment.

She said that the minister of state for health was also taking the plan to the highest level with the EU to discuss other parts of it.

“When we do a plan, we have to put money in research, but then manufacturing must follow.

“So, we are going to invest €18 million in research in vaccines in Nigeria with full grants to some public research institutions and other implementing partners.

“We will be working closely with your ministry and of course your public institutions on that and we will be working closely also in a Team Europe spirit with Bulgaria.

“Manufacturing of vaccines is a Team Europe initiative with Africa on a continental level so we have other partners at African level.

“I also heard from the minister that you were aiming at having a biomedical institute in the capital and that’s also something we could look into and link to research but probably also research on vaccines as well.”

Isopi added that the EU had several other smaller projects in the pipeline in Nigeria on public health institutions and digital health that it would develop.

The Bulgarian Ambassador to Nigeria, Amb. Yanko Yordanov, said that on his arrival to Nigeria three years ago, his ambition was to change the pattern from business as usual to acting as a strategic partner of Nigeria.

He said that the partnership with Nigeria in the health sector was regarded as a partnership and an investment

in global health because Nigeria as a very big country was part of the global agenda for health care.

“The national plan is the first step; the implementation is what matters and Bulgaria is more than willing

to be part of this implementation, both as a partner who provides funding, but also with our own national expert base.

“So in Bulgaria, you can count on a vast array of experts in terms of research, development and implementation of vaccines.

“I can reassure you that what we are aiming to do is definitely a sustainable, long term partnership that will transcend throughout the years.”

Yordano added that “the EU is a generous organisation to Africa, and had taken note of Nigeria’s request for more funding and will do what is appropriate in that regard.”

Earlier, the Minister of State for Health and Social Welfare, Dr Tunji Alausa, commended the EU and Bulgaria for the generous effort towards the country.

He said that the partnership was triggered by COVID-19 and a need to begin to locally produce vaccines in Nigeria as the country was presently producing less than one per cent of the vaccines used in the country.

“Unfortunately in a country of 220 million people, it is shocking and sad to know and disappointing to us that we are producing less than one per cent of our vaccines.

“We are importing everything and vaccine should be one of the essential commodities that any country should produce.

“We know we have a lot of development partners working to help us but we have to build capacity. If our development partners should leave us today, we will be in a bigger trouble than where we were and research is the only base that we have to build a sustainable health care sector.”